Catégories
-
Adhesives
6
Amines
115
Amino Acids
210
Analytical Reagents
751
Antibiotics
275
Bioactive Small Molecules
806
Aroma Chemicals
247
Biochemicals
1158
Boronic Acids
4
Buffers
105
Building Blocks
2196
Carbohydrates
193
Catalysts
120
Chiral Compounds
77
Coccus nucifera oil
0
Detergents
63
Diagnostic Raw Materials
273
Flavours and Fragrance Materials
236
Fluorinated Products
68
Furans
7
Gases in Solution
53
Grignard Reagents
32
HPLC Reagents
8
Imidazoles
19
Indoles
48
Inorganic Chemicals
360
Ion-Pair Reagents
21
Ligands
81
Organics
1651
Oxazoles
3
Peptide Reagents
102
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
69
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
895
Salts
311
Sealing Compounds
1
Sherclin
1
Solvents
134
Stains & Indicators
324
Sugars
67
Tailor-made solutions
1
Testing Standards
4
Uncategorised
23
Water Analysis
12
Prednisolone
(12896812 | 50-24-8)
CAS: | 50-24-8 |
---|---|
Formule moléculaire: | C21H28O5 |
Masse moléculaire: | 360.44 |
Disponibilité: | Vérifier la disponibilité |
---|---|
Téléchargements: | Spécifications du produit | Fiche de données de sécurité [EN] |
12896812-5g | 5g | £108.90 | |
Commande en vrac |
12896812-5g | 5g | €152.50 | |
Commande en vrac |
12896812-5g | 5g | $163.40 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 12896812 | ||||
Product Name | Prednisolone | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 50-24-8 | ||||
Molecular Formula | C21H28O5 | ||||
Molecular Weight | 360.44 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29372100 EXP 2937210000 IMP |
Spécifications du produit
Melting Point | 240 - 241 Deg C | ||||
Specific rotation | +96 to +102 | ||||
Heavy metals | <2ppm | ||||
Loss on Drying | <0.5% | ||||
Assay | 97 - 103% | ||||
Appearance | White crystalline powder |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|